An Open Label, Randomized, Single-dose, 4-period Cross-over Study to Compare the Pharmacokinetics and Safety Following Administration of JLP-1401 and Co-administration of Telmisartan/Amlodipine and Rosuvastatin in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2019
Price : $35 *
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 27 Aug 2019 Status changed from recruiting to completed.
- 14 Nov 2018 Status changed from not yet recruiting to recruiting.
- 24 Oct 2018 New trial record